List of Chapters/Sections(Table Of Content)
1 Diagnostic Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Diagnostic Radiopharmaceuticals
1.2 Diagnostic Radiopharmaceuticals Segment by Type
1.2.1 Global Diagnostic Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Technetium 99
1.2.3 Fluorine 18
1.2.4 Other
1.3 Diagnostic Radiopharmaceuticals Segment by Application
1.3.1 Global Diagnostic Radiopharmaceuticals Sales Comparison by Application: (2021-2027)
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Diagnostic Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Diagnostic Radiopharmaceuticals Revenue 2016-2027
1.4.2 Global Diagnostic Radiopharmaceuticals Sales 2016-2027
1.4.3 Diagnostic Radiopharmaceuticals Market Size by Region: 2016 Versus 2021 Versus 2027
2 Diagnostic Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Manufacturers (2016-2021)
2.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Diagnostic Radiopharmaceuticals Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Diagnostic Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Diagnostic Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Diagnostic Radiopharmaceuticals Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Diagnostic Radiopharmaceuticals Players Market Share by Revenue
2.5.3 Global Diagnostic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Diagnostic Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Diagnostic Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Diagnostic Radiopharmaceuticals Sales by Country
3.3.2 North America Diagnostic Radiopharmaceuticals Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Diagnostic Radiopharmaceuticals Sales by Country
3.4.2 Europe Diagnostic Radiopharmaceuticals Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Diagnostic Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Diagnostic Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Diagnostic Radiopharmaceuticals Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Diagnostic Radiopharmaceuticals Sales by Country
3.6.2 Latin America Diagnostic Radiopharmaceuticals Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Diagnostic Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Diagnostic Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Diagnostic Radiopharmaceuticals Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Type (2016-2021)
4.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Type (2016-2021)
4.3 Global Diagnostic Radiopharmaceuticals Price by Type (2016-2021)
5 Global Diagnostic Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Diagnostic Radiopharmaceuticals Sales Market Share by Application (2016-2021)
5.2 Global Diagnostic Radiopharmaceuticals Revenue Market Share by Application (2016-2021)
5.3 Global Diagnostic Radiopharmaceuticals Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Cardinal Health
6.1.1 Cardinal Health Corporation Information
6.1.2 Cardinal Health Description and Business Overview
6.1.3 Cardinal Health Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Cardinal Health Diagnostic Radiopharmaceuticals Product Portfolio
6.1.5 Cardinal Health Recent Developments/Updates
6.2 GE Healthcare
6.2.1 GE Healthcare Corporation Information
6.2.2 GE Healthcare Description and Business Overview
6.2.3 GE Healthcare Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.2.4 GE Healthcare Diagnostic Radiopharmaceuticals Product Portfolio
6.2.5 GE Healthcare Recent Developments/Updates
6.3 Curium Pharma
6.3.1 Curium Pharma Corporation Information
6.3.2 Curium Pharma Description and Business Overview
6.3.3 Curium Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Curium Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.3.5 Curium Pharma Recent Developments/Updates
6.4 Jubilant Pharma
6.4.1 Jubilant Pharma Corporation Information
6.4.2 Jubilant Pharma Description and Business Overview
6.4.3 Jubilant Pharma Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jubilant Pharma Diagnostic Radiopharmaceuticals Product Portfolio
6.4.5 Jubilant Pharma Recent Developments/Updates
6.5 Bracco Imaging
6.5.1 Bracco Imaging Corporation Information
6.5.2 Bracco Imaging Description and Business Overview
6.5.3 Bracco Imaging Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bracco Imaging Diagnostic Radiopharmaceuticals Product Portfolio
6.5.5 Bracco Imaging Recent Developments/Updates
6.6 Advanced Accelerator Applications
6.6.1 Advanced Accelerator Applications Corporation Information
6.6.2 Advanced Accelerator Applications Description and Business Overview
6.6.3 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Advanced Accelerator Applications Diagnostic Radiopharmaceuticals Product Portfolio
6.6.5 Advanced Accelerator Applications Recent Developments/Updates
6.7 SIEMENS
6.6.1 SIEMENS Corporation Information
6.6.2 SIEMENS Description and Business Overview
6.6.3 SIEMENS Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.4.4 SIEMENS Diagnostic Radiopharmaceuticals Product Portfolio
6.7.5 SIEMENS Recent Developments/Updates
6.8 China Isotope & Radiation
6.8.1 China Isotope & Radiation Corporation Information
6.8.2 China Isotope & Radiation Description and Business Overview
6.8.3 China Isotope & Radiation Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.8.4 China Isotope & Radiation Diagnostic Radiopharmaceuticals Product Portfolio
6.8.5 China Isotope & Radiation Recent Developments/Updates
6.9 Dongcheng Pharmaceutical Group
6.9.1 Dongcheng Pharmaceutical Group Corporation Information
6.9.2 Dongcheng Pharmaceutical Group Description and Business Overview
6.9.3 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Dongcheng Pharmaceutical Group Diagnostic Radiopharmaceuticals Product Portfolio
6.9.5 Dongcheng Pharmaceutical Group Recent Developments/Updates
6.10 Lantheus
6.10.1 Lantheus Corporation Information
6.10.2 Lantheus Description and Business Overview
6.10.3 Lantheus Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Lantheus Diagnostic Radiopharmaceuticals Product Portfolio
6.10.5 Lantheus Recent Developments/Updates
6.11 Eli Lilly
6.11.1 Eli Lilly Corporation Information
6.11.2 Eli Lilly Diagnostic Radiopharmaceuticals Description and Business Overview
6.11.3 Eli Lilly Diagnostic Radiopharmaceuticals Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Eli Lilly Diagnostic Radiopharmaceuticals Product Portfolio
6.11.5 Eli Lilly Recent Developments/Updates
7 Diagnostic Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Diagnostic Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Diagnostic Radiopharmaceuticals
7.4 Diagnostic Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Diagnostic Radiopharmaceuticals Distributors List
8.3 Diagnostic Radiopharmaceuticals Customers
9 Diagnostic Radiopharmaceuticals Market Dynamics
9.1 Diagnostic Radiopharmaceuticals Industry Trends
9.2 Diagnostic Radiopharmaceuticals Growth Drivers
9.3 Diagnostic Radiopharmaceuticals Market Challenges
9.4 Diagnostic Radiopharmaceuticals Market Restraints
10 Global Market Forecast
10.1 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Type (2022-2027)
10.2 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Application (2022-2027)
10.3 Diagnostic Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Diagnostic Radiopharmaceuticals by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Diagnostic Radiopharmaceuticals by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
